Publicacións nas que colabora con Miguel de Górgolas Hernández-Mora (6)

2008

  1. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313

2004

  1. Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 3, pp. 540-543

2002

  1. Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999

    Sexually Transmitted Infections, Vol. 78, Núm. 4, pp. 255-260

2001

  1. Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy

    HIV Clinical Trials, Vol. 2, Núm. 5, pp. 429-437

2000

  1. Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires

    AIDS, Vol. 14, Núm. 10, pp. 1439-1447

1999

  1. A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients

    AIDS, Vol. 13, Núm. 13, pp. 1727-1735